symbol,price,beta,volAvg,mktCap,lastDiv,range,changes,companyName,currency,cik,isin,cusip,exchange,exchangeShortName,industry,website,description,ceo,sector,country,fullTimeEmployees,phone,address,city,state,zip,dcfDiff,dcf,image,ipoDate,defaultImage,isEtf,isActivelyTrading,isAdr,isFund
AURA,8.6,0,52865,328495060,0,7.94-14.38,0.14,"Aura Biosciences, Inc.",USD,0001501796,US05153U1079,05153U107,NASDAQ Global Market,NASDAQ,Biotechnology,https://www.aurabiosciences.com,"Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develops AU-011 in additional ocular oncology indications, including choroidal metastases. The company was incorporated in 2009 and is headquartered in Cambridge, Massachusetts.",Dr. Elisabet  de los Pinos Ph.D.,Healthcare,US,70,617 500 8864,85 Bolton Street,Cambridge,MA,02140,,0,https://financialmodelingprep.com/image-stock/AURA.png,2021-10-29,False,False,True,False,False
